(Q37252893)

19 August 2017

1 reference

title

ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas (English)

1 reference

19 August 2017

Elena Quaglino

1

1 reference

19 August 2017

Cristina Mastini

series ordinal

2

1 reference

19 August 2017

Guido Forni

series ordinal

3

1 reference

19 August 2017

Federica Cavallo

series ordinal

4

1 reference

19 August 2017

1 August 2008

1 reference

Current Protocols in Immunology

19 August 2017

1 reference

19 August 2017

Chapter 20

1 reference

19 August 2017

Unit 20.9.1-20.9-10

1 reference

Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma

19 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM2009S82

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM2009S82

Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM2009S82

Human ErbB-2 (Her-2) transgenic mice: a model system for testing Her-2 based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM2009S82

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM2009S82

10.1002/0471142735.IM2009S82

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference